A summary of the included study characteristics. حسب Zahra Tajik (20752452)

Decrease of apolipoprotein-A1 by gender and age in US cohort. حسب Thierry Poynard (38084)

HVR1-swap compensatory E1/E2 substitutions typically decrease virus entry dependency on SR-BI. حسب Christina Holmboe Olesen (11154333)

Number of injuries as a result of traffic collisions in prefectures with low population density for the January 2018 to June 2022 period. حسب Ryo Shimada (6444365)

Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 ^a indicates ≥1.50 SD (19.2) from the mean (34.... حسب Luke R. Cavanah (19022435)

Top 10 important features with mean decrease in Gini index (A) and distribution of minimal depth (B). حسب Hyun Kyung Lim (9547300)

Mean amplitude values during a complete 360° rotation for the iliocostalis muscle. حسب Christoph Anders (4068499)

Mean amplitude values during a complete 360° rotation for the longissimus muscle. حسب Christoph Anders (4068499)

Mean amplitude values during a complete 360° rotation for the multifidus muscle. حسب Christoph Anders (4068499)

Mean T2* and T2 relaxation time of the 10 participants. حسب Charlotte Zaeske (12101949)

Mean T2* and T2 relaxation time of the 10 participants. حسب Charlotte Zaeske (12101949)

Decreased production of antiviral factors in patients infected with SARS-CoV-2 due to reduced TLR7 expression حسب Julia Cataldo Lima (22811497)

"…A decrease in pattern recognition receptors (PRRs) was also observed at both the gene and protein levels. …"

PGRN decreased Dectin-2 expression on the surface of macrophages and neutrophils. حسب Jiayu Liu (3951515)

Pom-resistant PEL cells have decreased expression of cereblon. حسب Prabha Shrestha (776391)

Study Flow Diagram. حسب Elizabeth S. Munroe (21568166)

CPSF6 protein expression is decreased in virus-infected cells. حسب Yong Ge (816832)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)